Wieczorek J, Mordarski M
Arch Immunol Ther Exp (Warsz). 1979;27(3):433-9.
Antifungal activity of antibiotic Wr-142 FPG was evaluated in vitro and in vivo. In vitro, the minimal inhibitory concentration (MIC) for Candida and Rhodotorula was 0.1 microgram/ml (preparation I) and 0.003 microgram/ml (preparation II). In vivo, experiments were carried out with model of subacute candidiasis in BALB mice. The criteria for antifungal activity of Wr-142 FPG were based on survival time of infected animals and numbers of live C. albicans cells in the kidneys and spleen of animals infected and treated with the antibiotics. Even a single intraperitoneal injection of Wr-142 FPG in mice with subacute candidiosis decidedly in prolonged survival time. Antibiotic Wr-142 injected subcutaneously on five consecutive days diminished the numbers of C. albicans cells, or even eliminated them entirely from the kidneys and spleens of the mice.
对抗生素Wr-142 FPG的抗真菌活性进行了体外和体内评估。在体外,对念珠菌和红酵母的最小抑菌浓度(MIC)分别为0.1微克/毫升(制剂I)和0.003微克/毫升(制剂II)。在体内,以BALB小鼠的亚急性念珠菌病模型进行实验。Wr-142 FPG抗真菌活性的标准基于感染动物的存活时间以及用抗生素感染和治疗的动物肾脏和脾脏中白色念珠菌活细胞的数量。即使对患有亚急性念珠菌病的小鼠进行单次腹腔注射Wr-142 FPG也能显著延长存活时间。连续五天皮下注射抗生素Wr-142可减少小鼠肾脏和脾脏中白色念珠菌细胞的数量,甚至可将其完全清除。